RH Capital

rhcapital.vc

VCMatch tracks RH Capital as an investor focused on Medtech, Biotech, and Digital Health companies, Pre-Seed and Seed rounds, United States markets, and $500k to $1.5m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$500k to $1.5m

Stages

Pre-Seed, Seed, Series A, Series B

Focus Areas

Medtech, Biotech, Digital Health

Geography

United States

Investment Thesis

RH Capital positions itself as an “impact-first venture capital fund” that combines a traditional venture lens with an explicit commitment to health equity in women’s health. The firm targets early-stage, high-impact startups that can “improve outcomes, access, affordability and health equity in women’s health,” while also pursuing market returns (“We do not seek concessionary returns”). They operate as a for-profit fund affiliated with the non-profit Rhia Ventures to align private-sector investing with reproductive and maternal health equity, and pair sector expertise (including the Women’s Health Innovation Council) with hands-on support, board involvement, and follow-on reserves to catalyze growth.

Is RH Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

RH Capital is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Medtech, Biotech, Digital Health, and Pharma, especially across United States, with public check-size signals around $500k to $1.5m.

Focus statement

RH Capital invests primarily in Seed to Series A women’s health startups across life sciences (devices, diagnostics, therapeutics), digital health, health services, and consumer health, with a near-term US market focus. Their checks typically range from $500K to $1.5M for a first check and they reserve capital for follow-ons.

Value Add

Explicitly "impact-first" but non-concessionary—screens deals both for venture returns and for social impact.
Led by women and highly founder-diverse (portfolio includes nearly 90% companies founded or led by women or people of color).
Close collaboration with Rhia Ventures (non-profit) and use of the Women’s Health Innovation Council and expert panels (WHIC supported by the Bill & Melinda Gates Foundation) for due diligence and portfolio support.
Focus on historically underserved populations (BIPOC, rural, LGBTQIA+, low-income) and culturally intentional care as core investment criteria.
Operationally hands-on investor that prefers board involvement (director or observer) and is willing to lead or participate in syndicates.
Avoids investing in competitors to prevent conflicts of interest.